Careful analysis of an unusual precipitate identifies defects.
A systematic approach facilitates formulation component selection.
Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.
An algorithmic approach to fine tune facility design and predict capacity.
Regulatory flexibility can make continuous improvement possible.
A true visionary leadership is required to drive the progress of operational excellence programs in biopharmaceutical organizations
A systematic approach facilitates formulation component selection.
How will implementing Quality by Design strategies affect your compliance status?
Rolling-tube system balances scale-up accuracy and thoroughput.
Regulatory flexibility can make continuous improvement possible.
Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.
Regulatory flexibility can make continuous improvement possible.
Intact protein LC–MS detected a mass variance of 62 Da and peptide mapping located a difference of two amino acids.
How to produce Plasmid DNA in a high-cell-density culture.
Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.
The authors give special consideration factors affecting blow–fill–seal technology.
Identifying issues in the factory that traditionally arise in the field minimized onsite equipment rework and subsequent qualification work.
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Rolling-tube system balances scale-up accuracy and thoroughput.
Intact protein LC–MS detected a mass variance of 62 Da and peptide mapping located a difference of two amino acids.
The authors describe challenges faced in transfer and scale-up of a fermentation process.
Regulatory flexibility can make continuous improvement possible.
Regulatory flexibility can make continuous improvement possible.
Biomanufacturers should follow a risk-based approach to decide which methods to use to characterize their products.
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).